Article courtesy of Dr. Joel Kahn, MD, who is a Clinical Professor of Medicine at Wayne State University School of Medicine, one of the world’s top cardiologists, a best-selling author, lecturer, and a leading expert in plant-based nutrition and holistic care.
Dr. Kahn is one of the featured speakers at the A4M 32nd Annual Spring Congress being held in West Palm Beach, Florida on May 3 to 5, 2024. He will be taking part in the sessions on Nourishing Health: Optimizing Nutrition, Decoding Metabolic Dysfunction, and Unveiling Genetic Influences.
The lipoprotein(a) [Lp(a)] field is rapidly evolving on many fronts, including understanding of the association between Lp(a) levels and cardiovascular disease (CVD) risk in different contexts, and how best to manage other CVD risk factors in patients with elevated Lp(a).
